Malignant Transformation and Long-Term Outcome of Oral and Laryngeal Leukoplakia
Journal of Clinical Medicine · 25.06.2023 · 12 (13) · 4255
DOI: 10.3390/jcm12134255 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 25.06.2023. Verfasst von Botond Bukovszky und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Semmelweis University, 1122 Budapest, Hungary. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Laboratories Program, Hungarian Thematic Excellence Program, Investment in the Future.
Abstract (Originalsprache)
Background
Oral or laryngeal leukoplakia has an increased risk for malignant transformation but the risk of the two anatomical sites has not been compared to each other yet. Materials and Methods: Clinical data of 253 patients with leukoplakia (oral = 221 or laryngeal = 32) enrolled from January 1996 to January 2022 were analyzed. One hundred and seventy underwent biopsy and 83 did not. The mean follow-up time was 148.8 months. Risk factors for the malignant transformation of leukoplakia were identified using Cox proportional hazard models.
Results
In the oral or laryngeal group, the rate of cancer was 21.7% and 50% (p = 0.002), respectively. The 10-year estimated malignant transformation was 15.1% and 42% (p < 0.0001), respectively. The laryngeal group had an increased risk of malignant transformation (p < 0.0001). The 5-year estimated survival with leukoplakia-associated cancer for the oral or laryngeal group was 40.9% and 61.1% (p = 0.337), respectively. Independent predictors of malignant transformation in the oral group were dysplasia and the grade of dysplasia of the leukoplakia, and in the laryngeal group, dysplasia had a significant impact. The malignant transformation rate was low for oral patients without biopsy or with no dysplasia, 3.9% and 5.1%, respectively. The malignant transformation occurred over 10 years.
Conclusions
Patients with dysplastic leukoplakia have an increased risk of malignant transformation, but the risk is higher with laryngeal than with oral leukoplakia. There is no significant difference between the groups regarding survival with leukoplakia-associated cancer. Oral patients with no dysplastic lesions have a low risk of malignant transformation. A complete excision and long-term follow up are suggested for high-risk patients to diagnose cancer in an early stage and to control late (over 10 years) malignant events.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, Semmelweis University, 1122 Budapest, Hungary.
- Department of Oral Diagnostics, Faculty of Dentistry, Semmelweis University, 1088 Budapest, Hungary.
- Center of Radiotherapy and the National Tumor Biology Laboratory, 1122 Budapest, Hungary.
- Department of Surgical and Molecular Pathology and the National Tumor Biology Laboratory, 1122 Budapest, Hungary.
- Multidisciplinary Centre of Head and Neck Tumours and the National Tumor Biology Laboratory, 1122 Budapest, Hungary.
ORCID-Profile: Botond Bukovszky
Förderung
- National Laboratories Program
- Hungarian Thematic Excellence Program
- Investment in the Future
Zitieren
APA
Bukovszky, B., Fodor, J., Tóth, E., Kocsis, Z. S., Oberna, F., Ferenczi, Ö., & Polgár, C. (2023). Malignant Transformation and Long-Term Outcome of Oral and Laryngeal Leukoplakia. Journal of Clinical Medicine, 12(13), 4255. https://doi.org/10.3390/jcm12134255
Vancouver
Bukovszky B, Fodor J, Tóth E, Kocsis ZS, Oberna F, Ferenczi Ö, et al. Malignant Transformation and Long-Term Outcome of Oral and Laryngeal Leukoplakia. Journal of Clinical Medicine. 2023;12(13):4255. doi:10.3390/jcm12134255
BibTeX
@article{Bukovszky2023,
author = {Bukovszky, Botond and Fodor, János and Tóth, Erika and Kocsis, Zsuzsa S and Oberna, Ferenc and Ferenczi, Örs and Polgár, Csaba},
title = {Malignant Transformation and Long-Term Outcome of Oral and Laryngeal Leukoplakia},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {13},
pages = {4255},
doi = {10.3390/jcm12134255}
}
EUVIMED